Welcome to BioIntercept
a trailblazer in regenerative medicine harnessing the power of exosome therapy to transform lives. Our innovative platform utilizes nano-sized vesicles derived from mesenchymal stem cells (MSCs) sourced from umbilical cords and other origins to deliver targeted regenerative molecules. .
Years of Research
Experience
Our Mission
To revolutionize healthcare through safe, scalable exosome-based therapies that promote regeneration and rejuvenation.
Our Vision
To be a global leader in advancing exosome therapy for healing, recovery, and healthy aging.
ABOUT US
BioIntercept: Science, Purpose, Progress
BioIntercept is dedicated to revolutionizing regenerative medicine through advanced exosome therapy. Our team of world-class scientists, clinicians, and industry experts leverages MSC-derived exosomes to develop therapies that promote tissue repair and rejuvenation. We are driven by a vision to address unmet medical needs, from stroke recovery to longevity, with innovative solutions backed by rigorous science and proprietary technology.
Technology
The Science Behind Healing
Pipeline
Our Development Path
01
Preliminary
Work
Collaborating with leading contract research organizations (CROs) and contract manufacturing organizations (CMOs) to scale GMP-compliant exosome production from MSC sources.
02
Development for Regenerative and Rejuvenative Conditions
Testing MSC-derived exosomes in relevant models, such as cerebral occlusion for stroke and aged mice for longevity. Key endpoints include reduced damage volume, improved functional scores.
03
Regulatory and CMC Strategy
Engaging in Pre-IND meetings with the FDA and pursuing GCP-compliant trials overseas, followed by IND filing for Biologics License Application (BLA) approval.
Testimonials
Our Happy Customers
I Am Very Happy To Come To This Clinic, I Get Very Good Service With Very Friendly Doctors
Alena Pale
